Standout Papers
Citation Impact
Citing Papers
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Genetic variability: The key problem in the prevention and therapy of RNA‐based virus infections
2003
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin
1994
Myasthenia Gravis
2016 Standout
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
1999
Manipulating the Immune System with Immune Globulin
1992
Small-Vessel Vasculitis
1997 Standout
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
Normal levels of IgG subclass in childhood determined by a sensitive ELISA
1993
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women
1989
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia
1988
Mucosal immunoglobulins
2005
Guillain-Barré syndrome
2016 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
IgG Fc Glycosylation in Human Immunity
2019
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
2015
Placental transport of immunoglobulin G
2003
Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis
1997
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
1997
Targeting of human switch recombination breakpoints: implications for the mechanism of μ - γ isotype switching
1999
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
1991 Standout
IgG4-Related Disease
2012 Standout
Intravenous immunoglobulin: regulatory perspectives on use and supply
2001
Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis
1988
Myasthenia Gravis
1994 Standout
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
1994
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
1993
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
1994
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients
1991
Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
1991
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Immune Thrombocytopenic Purpura
2002 Standout
Graft-versus-host disease
2009 Standout
Experience with intravenous immunoglobulin in myasthenia gravis
1989
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
IgG Subclass Distribution of Hepatitis B Surface Antigen Antibodies Induced in Children with Chronic Hepatitis B Infection after Interferon‐α Therapy
2000
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
2015
Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura
1988
IgG4-related disease
2014 Standout
Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
1989
Regulation of transcription factor NF KAPPA B in immune senescence
1998
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms
1987
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
2001 Standout
Guillain-Barr?? Syndrome
2004
Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura
1996
Immunoglobulin G4-associated cholangitis
2008
Polymyositis and dermatomyositis
2003 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Guillain-Barré syndrome
2005 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Dengue
2007 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
1983
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
WEGENER'S GRANULOMATOSIS
1995
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
The nontreatment of childhood idiopathic thrombocytopenic purpura
1987
Human Immunoglobulins: Classes, Subclasses, Genetic Variants, and Idiotypes
1973
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
2002 StandoutNobel
Zinc Therapy of Depressed Cellular Immunity in Acrodermatitis Enteropathica
1979
Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy
1987
Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions
1981 Standout
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
1987
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T Cells
2001 StandoutNobel
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
1985
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
1986
Kawasaki Disease: A Brief History
2000
Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature1
1987
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
1986 Standout
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE
1984
Long-term Consequences of Kawasaki Disease
1996 Standout
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia
1994 StandoutNobel
Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.
1983 StandoutNobel
Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals
1998
ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN
1984
IgG heavy chain allotypes (Gm) in autoimmune diseases.
1980
Impaired nuclear responsiveness to cytoplasmic signals in lymphocytes from elderly humans with depressed proliferative responses.
1986 StandoutNobel
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
2006 Science
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for Therapy
1984
Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion
1997 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
The Primary Immunodeficiencies
1984
Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976
1982
MANAGEMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
1983
Genetic factors predisposing to autoimmune diseases
1982
Takayasu's Arteritis and Ankylosing Spondylitis Report of Four Cases
1966
Surgery of the Spleen
1983
Defective Lymphoid Development in Mice Lacking Jak3
1995 StandoutScienceNobel
Takayasu's Arteritis
1967 Standout
Age Influence on the Immune System
1980
Nucleotide sequence divergence of mouse immunoglobulin gamma 1 and gamma 2b chain genes and the hypothesis of intervening sequence-mediated domain transfer.
1980 StandoutNobel
Works of A. Morell being referenced
Clinical Use of Intravenous Immunoglobulins
2000
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
1995
Safety of Intravenous Immunoglobulin Preparations: A Prospective Multicenter Study to Exclude the Risk of Non‐A, Non‐B Hepatitis
1991
[Familial autoimmune hemolytic animia (AIHA) with negative Coombs test, lymphocytopenia and hypogammaglobulinemia].
1975
IgG - subclass abnormalities in primary immunodeficiency diseases.
1975
In vivo Behaviour of Gamma Globulin Preparations1
1980
Human IgG Subclasses in Maternal and Fetal Serum
1971
Distribution of IgA Subclasses in Sera and Bone Marrow Plasma Cells of 21 Normal Individuals
1974
Correlation ofin vitro antibody synthesis with the outcome of intravenous ?-globulin treatment of chronic idiopathic thrombocytopenic purpura
1986
EVIDENCE FOR AN ASSOCIATION BETWEEN UNCOMMON Gm PHENOTYPES AND NEUROBLASTOMA
1977
IgG subclasses: Development of the serum concentrations in “normal” infants and children
1972
Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen
1983
Immunoglobulin patterns in humans over 95 years of age.
1975
Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study.
1976
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout